Li Zhuang
The University of Texas MD Anderson Cancer Center(US)Anhui Agricultural University(CN)Harbin Medical University(CN)Hubei University of Chinese Medicine(CN)Zhujiang Hospital(CN)Dongguan People’s Hospital(CN)Blood Center of Zhejiang Province(CN)Zhejiang Shuren University(CN)National Institutes for Food and Drug Control(CN)Southern Medical University Shenzhen Hospital(CN)Hangzhou Red Cross Hospital(CN)First Affiliated Hospital of Harbin Medical University(CN)First Affiliated Hospital Zhejiang University(CN)Southern Medical University(CN)Zhejiang University(CN)
Publications by Year
Research Areas
Ferroptosis and cancer prognosis, Hepatocellular Carcinoma Treatment and Prognosis, RNA modifications and cancer, Cancer, Lipids, and Metabolism, Liver Disease Diagnosis and Treatment
Most-Cited Works
- → Targeting ferroptosis as a vulnerability in cancer(2022)2,045 cited
- → DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer(2021)1,697 cited
- → Energy-stress-mediated AMPK activation inhibits ferroptosis(2020)1,075 cited
- → Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis(2023)1,059 cited
- → BAP1 links metabolic regulation of ferroptosis to tumour suppression(2018)1,008 cited
- → mTORC1 couples cyst(e)ine availability with GPX4 protein synthesis and ferroptosis regulation(2021)678 cited